CYTOSORBENTS CORPORATION Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CYTOSORBENTS CORPORATION stock issued during period, shares, new issues for the quarter ending 2021-12-31 was 0.00 shares.
- CYTOSORBENTS CORPORATION stock issued during period, shares, new issues for the quarter ending 2021-09-30 was 0.00 shares.
- CYTOSORBENTS CORPORATION stock issued during period, shares, new issues for the quarter ending 2021-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- CYTOSORBENTS CORPORATION stock issued during period, shares, new issues for the quarter ending 2021-03-31 was 4.30M shares, a 18.58% increase year-over-year.
- CYTOSORBENTS CORPORATION stock issued during period, shares, new issues for fiscal 2025 was 7.67M shares, a 2001727.42% increase from fiscal 2024.
- CYTOSORBENTS CORPORATION stock issued during period, shares, new issues for fiscal 2024 was 383.00 shares, a 100.00% decline from fiscal 2023.
- CYTOSORBENTS CORPORATION stock issued during period, shares, new issues for fiscal 2023 was 10.39M shares.
- CYTOSORBENTS CORPORATION stock issued during period, shares, new issues for fiscal 2021 was 4.30M shares, a 0.00% change from fiscal 2020.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2025-12-31 | 7.67M shares 10-K · filed 2026-03-30 | |
| 2024-12-31 | 383.00 shares 10-K · filed 2026-03-30 | |
| 2023-12-31 | 10.39M shares 10-K · filed 2025-03-31 | |
| 2022-12-31 | 0.00 shares 10-Q · filed 2024-11-07 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 4.30M shares 10-K · filed 2022-03-10 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 4.30M shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 4.30M shares derived: sum of 4 quarters · filed 2021-08-03 |
| 2021-03-31 | 4.30M shares 10-Q · filed 2021-05-04 | 4.98M shares derived: sum of 4 quarters · filed 2021-05-04 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | 4.30M shares 10-K · filed 2021-03-09 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | |
| 2020-06-30 | 674.11K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | |
| 2020-03-31 | 3.63M shares 10-Q · filed 2020-05-05 | |
| 2019-12-31 | 2.63M shares 10-K · filed 2020-03-05 | |
| 2018-12-31 | 1.52M shares 10-K · filed 2019-03-07 | |
| 2017-12-31 | 550.00K shares 10-K · filed 2019-03-07 | |
| 2017-09-30 | 282.39K shares 10-Q · filed 2017-11-09 | |
| 2015-12-31 | 28.88K shares 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |